EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Regional, geographic, and racial/ethnic variation in glycemic control in a national sample of veterans with diabetes






Diabetes Care 34(4): 938-943

Regional, geographic, and racial/ethnic variation in glycemic control in a national sample of veterans with diabetes

We performed a retrospective analysis of a national cohort of veterans with diabetes to better understand regional, geographic, and racial/ethnic variation in diabetes control as measured by HbA(1c). A retrospective cohort study was conducted in a national cohort of 690,968 veterans with diabetes receiving prescriptions for insulin or oral hypoglycemic agents in 2002 that were followed over a 5-year period. The main outcome measures were HbA(1c) levels (as continuous and dichotomized at ≥8.0%). Relative to non-Hispanic whites (NHWs), HbA(1c) levels remained 0.25% higher in non-Hispanic blacks (NHBs), 0.31% higher in Hispanics, and 0.14% higher in individuals with other/unknown/missing racial/ethnic group after controlling for demographics, type of medication used, medication adherence, and comorbidities. Small but statistically significant geographic differences were also noted with HbA(1c) being lowest in the South and highest in the Mid-Atlantic. Rural/urban location of residence was not associated with HbA(1c) levels. For the dichotomous outcome poor control, results were similar with race/ethnic group being strongly associated with poor control (i.e., odds ratios of 1.33 [95% CI 1.31-1.35] and 1.57 [1.54-1.61] for NHBs and Hispanics vs. NHWs, respectively), geographic region being weakly associated with poor control, and rural/urban residence being negligibly associated with poor control. In a national longitudinal cohort of veterans with diabetes, we found racial/ethnic disparities in HbA(1c) levels and HbA(1c) control; however, these disparities were largely, but not completely, explained by adjustment for demographic characteristics, medication adherence, type of medication used to treat diabetes, and comorbidities.


Accession: 055445291

PMID: 21335370

DOI: 10.2337/dc10-1504



Related references

Wendel, C.S.; Shah, J.H.; Duckworth, W.C.; Hoffman, R.M.; Mohler, M.Jane.; Murata, G.H., 2006: Racial and ethnic disparities in the control of cardiovascular disease risk factors in Southwest American veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study. Racial/ethnic disparities in cardiovascular disease complications have been observed in diabetic patients. We examined the association between race/ethnicity and cardiovascular disease risk factor control in a large cohort of insulin-treated veter...

Lynch, C.P.; Strom, J.L.; Egede, L.E., 2011: Variation in quality of care indicators for diabetes in a national sample of veterans and non-veterans. Veterans have a disproportionately higher burden of type 2 diabetes. It is unclear whether veterans with diabetes have better self-care behaviors or receive better quality of care than non-veterans. The objective was to examine differences in diab...

Harris, M.I.; Eastman, R.C.; Cowie, C.C.; Flegal, K.M.; Eberhardt, M.S., 1999: Racial and ethnic differences in glycemic control of adults with type 2 diabetes. To evaluate glycemic control in a representative sample of U.S. adults with type 2 diabetes. The Third National Health and Nutrition Examination Survey included national samples of non-Hispanic whites, non-Hispanic blacks, and Mexican Americans ag...

Axon, R.Neal.; Gebregziabher, M.; Echols, C.; Msph, G.Gilbert.; Egede, L.E., 2012: Racial and ethnic differences in longitudinal blood pressure control in veterans with type 2 diabetes mellitus. Few studies have examined racial/ethnic differences in blood pressure (BP) control over time, especially in an equal access system. We examined racial/ethnic differences in longitudinal BP control in Veterans with type 2 diabetes. We collected dat...

Cummings, D.M.; Doherty, L.; Howard, G.; Howard, V.J.; Safford, M.M.; Prince, V.; Kissela, B.; Lackland, D.T., 2010: Blood pressure control in diabetes: temporal progress yet persistent racial disparities: national results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Despite widespread dissemination of target values, achieving a blood pressure of <130/80 mmHg is challenging for many individuals with diabetes. The purpose of the present study was to examine temporal trends in blood pressure control in hypert...

Shipman, K.Elizabeth.; Jawad, M.; Sullivan, K.Marie.; Ford, C.; Gama, R., 2015: Ethnic/racial determinants of glycemic markers in a UK sample. To investigate possible causes for previously reported glycemia-independent South Asian-white differences in HbA1c. Demographic and laboratory data on non-diabetic patients from primary care were analyzed. Linear regression models measured the ass...

Yeboah-Korang, A.; Kleppinger, A.; Fortinsky, R.H., 2011: Racial and ethnic group variations in service use in a national sample of Medicare home health care patients with type 2 diabetes mellitus. Type 2 diabetes mellitus is known to affect adults in racial and ethnic minority groups disproportionately. When diabetes mellitus-related symptoms lead to the need for skilled care in the community-dwelling Medicare population, physicians can ord...

Tan, E.; Yang, W.; Pang, B.; Dai, M.; Loh, F.Ellen.; Hogan, P., 2016: Geographic Variation in Antidiabetic Agent Adherence and Glycemic Control Among Patients with Type 2 Diabetes. Medication nonadherence is an imperative public health concern. Among patients with type 2 diabetes mellitus (T2DM), poor adherence to antidiabetic agents is strongly associated with suboptimal glycemic control. Poor adherence and hyperglycemia gr...

Levin, S.R.; Coburn, J.W.; Abraira, C.; Henderson, W.G.; Colwell, J.A.; Emanuele, N.V.; Nuttall, F.Q.; Sawin, C.T.; Comstock, J.P.; Silbert, C.K., 2000: Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Microalbuminuria can reflect the progress of microvascular complications and may be predictive of macrovascular disease in type 2 diabetes. The effect of intensive glycemic control on microalbuminuria in patients in the U.S. who have had type 2 di...

Murata, G.H.; Shah, J.H.; Hoffman, R.M.; Wendel, C.S.; Adam, K.D.; Solvas, P.A.; Bokhari, S.U.; Duckworth, W.C., 2003: Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). To examine the effect of intensified self-monitored blood glucose (SMBG) testing on glycemic control. Subjects with stable, insulin-treated type 2 diabetes performed SMBG using an electronic blood glucose meter before all meals and at bedtime for...